Late‑stage deals dominate startup funding in April to May

Seed-stage companies secured $52.2m as total investments reached $214m.

Late-stage deals were the dominant source of startup funding in Singapore, accounting for $157.8m, or 73.9%, of the $214m raised between 1 April and 31 May, according to Tracxn.

Seed-stage startups attracted $52.2m, representing 24.4% of total funding, whilst early-stage companies raised $3.7m for the period.

Amongst completed quarters, late-stage funding reached $2.4b in the first quarter (Q1) of 2026 and $460m in Q2 2025.

Seed-stage funding stood at $105.8m in Q1 2026 and $48.5m in Q2 2025, whilst early-stage funding totalled $459.6m and $218.1m, respectively.

The latest funding activity was led by Silicon Box’s $150m round, followed by Simple Chain at $15m, Biobot Surgical at $7.8m, Brano Therapeutics at $6.8m, and Atlas at $6m.

Follow the link for more news on

Chart of the Day

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia